BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
R. de Nooijer, C.J.N. Verkleij, J.H. von der Thüsen, J.W. Jukema, E.E. van der Wall, Th. J.C. van Berkel, A.H. Baker, E.A.L. Biessen. Lesional Overexpression of Matrix Metalloproteinase-9 Promotes Intraplaque Hemorrhage in Advanced Lesions But Not at Earlier Stages of AtherogenesisArteriosclerosis, Thrombosis, and Vascular Biology 2006; 26(2): 340 doi: 10.1161/01.ATV.0000197795.56960.64
2
Marilyn A. Roubidoux, Gerald L. LeCarpentier, J. Brian Fowlkes, Brett Bartz, Deepa Pai, Sasha P. Gordon, Anne F. Schott, Timothy D. Johnson, Paul L. Carson. Sonographic Evaluation of Early-Stage Breast Cancers That Undergo Neoadjuvant ChemotherapyJournal of Ultrasound in Medicine 2005; 24(7): 885 doi: 10.7863/jum.2005.24.7.885
3
Camila Salata, Samara Cristina Ferreira-Machado, André Luiz Mencalha, Cherley Borba Vieira de Andrade, Vera Maria Araújo de Campos, Carlos Alberto Mandarim-de-Lacerda, Carlos Eduardo deAlmeida. Chemotherapy and radiation regimens to breast cancer treatment induce changes in mRNA levels of renin–angiotensin system related genes in cardiac tissueJournal of the Renin-Angiotensin-Aldosterone System 2013; 14(4): 330 doi: 10.1177/1470320312465218
4
Ozge Cevik, Hilal Acidereli, Fatma Aysun Turut, Sahin Yildirim, Ceyda Acilan. Cabazitaxel exhibits more favorable molecular changes compared to other taxanes in androgen‐independent prostate cancer cellsJournal of Biochemical and Molecular Toxicology 2020;  doi: 10.1002/jbt.22542
5
Najibeh Shekari, Mahsa Javadian, Mottahareh Ghasemi, Behzad Baradaran, Masoud Darabi, Tohid Kazemi. Synergistic Beneficial Effect of Docosahexaenoic Acid (DHA) and Docetaxel on the Expression Level of Matrix Metalloproteinase-2 (MMP-2) and MicroRNA-106b in Gastric CancerJournal of Gastrointestinal Cancer 2020; 51(1): 70 doi: 10.1007/s12029-019-00205-0
6
Lisa D. Volk, Michael J. Flister, Christopher M. Bivens, Alan Stutzman, Neil Desai, Vuong Trieu, Sophia Ran. Nab-paclitaxel Efficacy in the Orthotopic Model of Human Breast Cancer Is Significantly Enhanced By Concurrent Anti–Vascular Endothelial Growth Factor A TherapyNeoplasia 2008; 10(6): 613 doi: 10.1593/neo.08302
7
Michael Douek, Jeffrey Tobias. How reliable is MRI for predicting extent of residual breast cancer with different primary medical therapies?Nature Clinical Practice Oncology 2005; 2(3): 128 doi: 10.1038/ncponc0105
8
Ewa Maj, Diana Papiernik, Joanna Wietrzyk. Antiangiogenic cancer treatment: The great discovery and greater complexity (Review)International Journal of Oncology 2016; 49(5): 1773 doi: 10.3892/ijo.2016.3709
9
Sajad Fakhri, Fatemeh Abbaszadeh, Masoumeh Jorjani, Mohammad Hossein Pourgholami. The effects of anticancer medicinal herbs on vascular endothelial growth factor based on pharmacological aspects: a review studyNutrition and Cancer 2019; : 1 doi: 10.1080/01635581.2019.1673451
10
F. Denis, A.V. Desbiez-Bourcier, C. Chapiron, F. Arbion, G. Body, L. Brunereau. Contrast enhanced magnetic resonance imaging underestimates residual disease following neoadjuvant docetaxel based chemotherapy for breast cancerEuropean Journal of Surgical Oncology (EJSO) 2004; 30(10): 1069 doi: 10.1016/j.ejso.2004.07.024
11
Richard J. Epstein. VEGF signaling inhibitors: More pro-apoptotic than anti-angiogenicCancer and Metastasis Reviews 2007; 26(3-4): 443 doi: 10.1007/s10555-007-9071-1
12
Sung Yi Hong, Myun Hee Lee, Kyung Sup Kim, Hyun Cheol Jung, Jae Kyung Roh, Woo Jin Hyung, Sung Hoon Noh, Seung Ho Choi. Adeno-associated virus mediated endostatin gene therapy in combination with topoisomerase inhibitor effectively controls liver tumor in mouse modelWorld Journal of Gastroenterology 2004; 10(8): 1191-1197 doi: 10.3748/wjg.v10.i8.1191